You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Letter to the Editor

Integrative Cancer Therapies

Impact Factor: 2.8 / 5-Year Impact Factor: 3.4

Journal Homepage Submission guidelines

Free access

Other

First published online September, 2004

Letter to the Editor

Volume 3, Issue 3

https://doi.org/10.1177/1534735404268115

Abstract

References

1. Burzynski SR. The present state of antineoplaston research (1). Integr Cancer Ther. 2004;3:47-58.

2. Prados M , Schold SC Jr , Fine HA , et al. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplat in administered intravenously for the treatment of recurrent malignant glioma. Neuro-oncol. 2003;5:96-103.

Browse journal

All articles Browse by year

Similar articles

Open access

Ethical,legal,and social implications of AI-enabled digital therapeutics: A comparative analysis of risk-based regulatory frameworks in the European Union and Japan

Open access

A study on the acceptance intention of digital therapeutics based on UTAUT2 and MIR

Open access

Response to the Letter to the Editor Regarding “Efficacy of Herbal Medicine Therapy Combined with Palliative Chemotherapy in Unresectable Advanced NSCLC: A Systematic Review and Meta-Analysis”

Retricted access

A Theoretical Approach to the Management of Paracetamol Overdosage